Afni, Inc.

Bloomington, IL Business servicesNAICS 561420

Self-funded health planPlan year 2025Renews January
2,313Participants+1% vs. prior year
$5.5MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#3 of 11Business services in ILBy participants

Overview

Afni, Inc. sponsors a self-funded health plan that covered 2,313 participants in plan year 2025, about the same as the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
2,313 · prior year 2,295
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Afni, Inc. Flexible Spending Plan, plan 503 (2,313 participants)
Stop-loss carrier
Blue Cross Blue Shield of Illinois
Broker compensation
$357K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Blue Cross Blue Shield of IllinoisStop-loss1,601$2.1M$102K
New York Life (life Insurance Company of North America)Long-term disability, Life, Short-term disability, Accidental Death and Dismemberment2,313$701K$144K
Metropolitan Life Insurance CompanyDental1,401$604K$29K
Cigna Health and Life Insurance CompanyAccident, Hospital Indemnity, Critical Illness713$213K$72K
Eyemed Vision CareVision1,290$128K$6K
MetLife Legal Plans, Inc.Legal178$41K$5K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$5.5M/ year

Estimated prescription spend: 2,313 participants × $2,371 national average per member. Usually higher once dependents are counted.

$143K–$352K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$42K–$104K
Lower-cost therapeutic alternatives$61K–$127K
Generic pricing vs. actual cost$26K–$79K
PBM contract terms$14K–$41K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Afni, Inc.
Sponsor EIN
37-1105130
Plan number
503
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 37-1105130 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Afni, Inc. 401(k) Plan
Type
401(k) plan
Participants
3,600

About this data

Source: Afni, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Afni, Inc..

Request a correction · Methodology